Safety and Efficacy of 7 Days on/7 Days off vs 14 Days on/7 Days off Schedules of Capecitabine in Patients With Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Colorectal Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients With Metastatic Colorectal Cancer: A Retrospective Review
Clin Colorectal Cancer 2021 Mar 16;[EPub Ahead of Print], E Bryson, E Sakach, U Patel, M Watson, K Hall, A Draper, C Davis, S Goyal, O Alese, M Akce, W Shaib, B El-Rayes, S Szabo, C WuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.